VivoSeq
Other

Diclofenac

0

Pipeline Programs↗

5

Active Trials↗

10

Companies Involved↗

Diclofenac is an early-stage landscape with 0 programs across 10 companies. The most active players are GSK, Javelin Pharmaceuticals, Iroko Pharmaceuticals, LLC.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalJ

Javelin Pharmaceuticals

0 programs

PreclinicalI

Iroko Pharmaceuticals, LLC

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalA

Anchen Pharmaceuticals, Inc

0 programs

PreclinicalT

Taisho Pharmaceutical Indonesia

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

52

clinical trials

Completed34 · 65%
Unknown status9 · 17%
Active, not recruiting2 · 4%
Terminated2 · 4%
Recruiting2 · 4%
Withdrawn2 · 4%
Other1 · 2%

Clinical Trials

Trial Activity

52 trials

Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac
Recruiting·WWashington State University·Phase 1·NCT06053411·30 enrolled
Diclofenac Dose Response Study
Recruiting·UUniversity of Maryland, Baltimore·Phase 1·NCT06636227·24 enrolled
Diclofenac as a KMO Inhibitor
Active, not recruiting·UUniversity of Maryland, Baltimore·Phase 1·NCT06029296·12 enrolled
Comparison Between Diclofenac and Sterile Water Injection for Relief of Labour Associated Bachache
Active, not recruiting·PPakistan Institute of Medical Sciences·N/A·NCT07203651·100 enrolled
Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children
Not yet recruiting·UUniversity of Calgary·Phase 3·NCT07145645·60 enrolled
Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT03074162·48 enrolled
Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium
Completed·GSK logoGSK·Phase 1·NCT02201238·18 enrolled
A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain
Completed·PPanineeya Mahavidyalaya Institute of Dental Sciences & Research Centre·Phase 4·NCT03221946·90 enrolled
Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%
Completed·AAnchen Pharmaceuticals, Inc·Phase 3·NCT01456611·749 enrolled
Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium
Completed·JJavelin Pharmaceuticals·Phase 1·NCT00509743·89 enrolled
Diclofenac Suppository to Control Pain During Flexible Cystoscopy
Completed·—·Phase 2·NCT01812928·60 enrolled
Counterpain PXM Versus Diclofenac Versus Piroxicam
Completed·TTaisho Pharmaceutical Indonesia·Phase 3·NCT07475663·180 enrolled
Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain
Completed·DDepomed·Phase 4·NCT02287350·51 enrolled
Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.
Completed·AAmzell·Phase 1·NCT06729073·34 enrolled
Effects of Topical Diclofenac on Tumor Metabolism
Completed·UUniversity Hospital Regensburg·Phase 4·NCT01935531·38 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)